Clinical Trial Update: A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of AK120 in adolescents with moderate-to-severe Atopic Dermatitis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• AK120

Snippet

Sponsor: Akeso | Conditions: Atopic Dermatitis | Phase 2 | Status: NOT_YET_RECRUITING